UPK2 and colorectal carcinoma: UPK2 positivity correlated with higher CRC-specific mortality in both cohorts (Cohort 1: HR 1.97, 95% CI 1.00-3.88; Cohort 2: HR 3.33, 95% CI 2.15-5.16).